ExploreWatchlistsPricing
  1. US-listed companies
  2. Eloxx Pharmaceuticals, Inc.
  3. Financials
  4. Return on equity (%)

Eloxx Pharmaceuticals, Inc. (ELOX)

Market cap
$106.38M
P/E ratio
SummaryFinancials
Period EndReturn on equity (%) (Million USD)YoY (%)
Dec 31, 2022-615.2+50.35%
Dec 31, 2021-409.2+174.81%
Dec 31, 2020-148.9+15.79%
Dec 31, 2019-128.6-12.42%
Dec 31, 2018-146.8-10.29%
Dec 31, 2017-163.7-23.31%
Jun 30, 2017-213.4+116.65%
Jun 30, 2016-98.5+8.29%
Jun 30, 2015-91+54.21%
Jun 30, 2014-59

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat